Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate MGL-3196 (Resmetirom) in Patients with MASH Who Have Undergone Liver Transplant for MASH Cirrhosis or Other Etiologies
Clinical Trial Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
Madrigal Pharmaceuticals, Inc.
Start Date
January 26, 2026
End Date
September 30, 2027
Administered By
Radiology, Abdominal Imaging
Awarded By
Madrigal Pharmaceuticals, Inc.
Start Date
January 26, 2026
End Date
September 30, 2027